Last reviewed · How we verify

NCT07113340

Carina™ Surgical Platform for Minimal Radical Gastrectomy

Active, enrolled NA Last updated 8 August 2025
What this trial tests

NA trial testing Carina™ Surgical Platform, developed by Ronovo Surgical, Inc in Robotic Gastrectomy in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 May 2025
Primary endpoint
1 October 2025
31 December 2025

Quick facts

Lead sponsorThe Affiliated Hospital of Qingdao University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 May 2025
Primary completion1 October 2025
Estimated completion31 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Affiliated Hospital of Qingdao University

Who can join

Adults 18 to 80, any sex, with Robotic Gastrectomy or Stomach Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the safety and effectiveness of the laparoscopic surgical system(Carina™ Surgical Platform, developed by Ronovo Surgical, Inc) for use in gastrectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The Affiliated Hospital of Qingdao University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07113340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing